Heron Therapeutics
NC - Cary
BiotechnologyFocus: Polymer-Based Delivery
Heron Therapeutics is a life sciences company focused on Polymer-Based Delivery.
OncologyGastroenterologyNeurologyMusculoskeletalInfectious Diseases
Open Jobs
3
Products & Portfolio (4)
APONVIE
aprepitant
Peak
INTRAVENOUS · EMULSION
Neurokinin 1 Antagonists
postoperative nauseavomiting (PONV) in adults
2022
0
CINVANTI
aprepitant
Peak
INTRAVENOUS · EMULSION
Neurokinin 1 Antagonists
delayed nauseavomiting associated with initialrepeat courses of highly emetogenic cancer chemotherapy (HEC) including high-dose cisplatin+2 more
2017
0
SUSTOL
granisetron
Peak
SUBCUTANEOUS · INJECTABLE
Serotonin 3 Receptor Antagonists
2016
30
ZYNRELEF KIT
bupivacaine and meloxicam
Peak
PERIARTICULAR · SOLUTION, EXTENDED RELEASE
Cyclooxygenase Inhibitors
2021
0
Pipeline & Clinical Trials
Withdraw treatment
HealthyClinical Trials (1)
NCT01416259A Phase I Study of the Effects of APF530 Exposure, Granisetron and Moxifloxacin
N/AB10 L-BPA Injection
MeningiomaClinical Trials (1)
NCT06668987A Study of the Boron Neutron Capture Therapy (BNCT) Using B10 L-BPA in Recurrent Meningioma
Phase 1/2B10 L-BPA Injection
Malignant Brain TumorsClinical Trials (1)
NCT07003139A Study of the Boron Neutron Capture Therapy (BNCT) Using B10 L-BPA in Malignant Brain Tumors
Phase 1/2HTX-034
BunionsClinical Trials (1)
NCT04398329Dose-Escalation Study of HTX-034 Following Bunionectomy
Phase 1/2HTX-011
AnalgesiaClinical Trials (1)
NCT03955211HTX-011 Administration Study in Planned Caesarean Section Procedure
Phase 2HTX-011
Postoperative PainClinical Trials (1)
NCT03015532Total Knee Arthroplasty Infiltration Study for Postoperative Analgesia
Phase 2Bupivacaine HCI without epinephrine
Post-Operative PainClinical Trials (1)
NCT04911062HTX-011 in Spinal Surgery
Phase 2HTX-011B
Postoperative PainClinical Trials (1)
NCT02689258Evaluation of the Efficacy and Safety of HTX-011 for Postoperative Analgesia Following Abdominoplasty Surgery
Phase 2HTX-011
Postoperative PainClinical Trials (1)
NCT03011333Phase 2B Upper Extremity Nerve Block Study
Phase 2Aprepitant injectable emulsion
COVID-19Clinical Trials (1)
NCT04470622Aprepitant Injectable Emulsion in Patients With COVID-19 (GUARDS-1)
Phase 2HTX-011
AnalgesiaClinical Trials (1)
NCT03922048Pediatric Postoperative Analgesia Herniorrhaphy Study
Phase 2HTX-011
Postoperative PainClinical Trials (1)
NCT03695367Phase 2 Herniorrhaphy Study for Opioid Elimination
Phase 2HTX-011
AnalgesiaClinical Trials (1)
NCT02471898A Phase 2, Two-Part Evaluation of the Efficacy and Safety of Locally Administered HTX-011 for Postoperative Analgesia Following Bunionectomy
Phase 2Drug: B10 L-BPA Injection
Head and Neck CancerClinical Trials (1)
NCT06952868Boron Neutron Capture Therapy With B10 L-BPA for Unresectable Recurrent Head and Neck Cancers
Phase 2HTX-011
Postoperative PainClinical Trials (1)
NCT02504580Pilot Herniorrhaphy Study for Postoperative Analgesia
Phase 2GRANISETRON EXTENDED RELEASE INJECTION
Chemotherapy-induced Nausea and VomitingClinical Trials (1)
NCT04085393Granisetron Extended Release Injection (GERSC) for the Prevention of Chemotherapy-induced Nausea and Vomiting
Phase 2HTX-011
Postoperative PainClinical Trials (1)
NCT03718039Phase 2 Bunionectomy HTX-011 Administration Study
Phase 2HTX-011A
Postoperative PainClinical Trials (1)
NCT02762929Evaluation of the Efficacy and Safety of Locally Administered HTX-011 for Postoperative Analgesia Following Bunionectomy
Phase 2HTX-011
AnalgesiaClinical Trials (1)
NCT03974932Total Knee Arthroplasty (TKA) Study of HTX-011 in an Multimodal Analgesic Regimen (MMA) Regimen
Phase 3HTX-011
Postoperative PainClinical Trials (1)
NCT03237481Phase 3 Herniorrhaphy Study for Postoperative Analgesia (EPOCH 2)
Phase 3APF530
Nausea and VomitingClinical Trials (1)
NCT00343460APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer
Phase 3HTX-011
Postoperative PainClinical Trials (1)
NCT03295721Bunionectomy Study for Postoperative Analgesia (EPOCH 1)
Phase 3Phase 3
Clinical Trials (1)
NCT02106494A Prospective, Multicenter, Study of APF530 (Granisetron) SC for Prevention of CINV in Patients Receiving HEC
Phase 3HTX-011
AnalgesiaClinical Trials (1)
NCT03907176Herniorrhaphy Study for Opioid Elimination
Phase 3HTX-011
AnalgesiaClinical Trials (1)
NCT06109428A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE
Phase 4Phase 4
Clinical Trials (1)
NCT05434663Safety Study of Repeat Doses of SUSTOL in Adults
Phase 4HTX-011
Postoperative PainClinical Trials (1)
NCT06109415A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE.
Phase 4Bupivacaine liposome injectable suspension
AnalgesiaClinical Trials (1)
NCT04102267Extended Delivery of Bupivacaine Study in Herniorrhaphy
Phase 4Bupivacaine Hydrochloride
AnalgesiaClinical Trials (1)
NCT05109312A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE. Master Protocol HTX-011-401.
Phase 4ZYNRELEF 200Mg-6Mg Extended-Release Solution
Post Operative Pain, AcuteClinical Trials (1)
NCT05863221ZYNRELEF® for Postoperative Analgesia After Laparoscopic Sleeve Gastrectomy
Phase 4Bupivacaine HCl
AnalgesiaClinical Trials (1)
NCT03705065Bupivacaine HCl PK and Safety in Augmentation Mammoplasty
Phase 4Open Jobs (3)
Interview Prep Quick Facts
Portfolio: 4 approved products, 31 clinical trials
Top TAs: Gastroenterology, Musculoskeletal
Open Roles: 3 active jobs
Portfolio Health
Peak4 (100%)
4 total products
Hiring Trend
Stable
3
Open Roles
+0
Added
-0
Filled/Removed
Based on last 4 crawl cycles